Minerva Neurosciences, Inc.
NERV
$2.39
-$0.045-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -4.73% | -88.19% | |||
| Gross Profit | 4.73% | 88.19% | |||
| SG&A Expenses | -18.28% | 0.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.55% | -13.69% | |||
| Operating Income | 13.55% | 13.69% | |||
| Income Before Tax | 13.17% | 12.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.17% | 12.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.17% | 12.15% | |||
| EBIT | 13.55% | 13.69% | |||
| EBITDA | 13.55% | 13.70% | |||
| EPS Basic | 13.17% | 12.15% | |||
| Normalized Basic EPS | 13.17% | 12.16% | |||
| EPS Diluted | 13.17% | 12.15% | |||
| Normalized Diluted EPS | 13.17% | 12.16% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||